RANGWALA RESHMA (EVP & Chief Medical Officer) sold 0.8% of their position (449.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $4.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/22/2026ACC: 0001825322-26-000006
Officer· EVP & Chief Medical Officer
Since Apr 2022
-449.00
Net shares
Net seller
$4.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
449.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−449.00
Price / share
$8.94
Trade value
$4.01K
% of position
0.8%
4/21/2026
56.74K→56.29K
Total
Net shares
−449.00
Net value
-$4.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2026 | S · Sale | −449.00 | $8.94 | $4.01K | 0.8% | 56.74K | 56.29K |
| Total | −449.00 | -$4.01K | ||||||
Derivative Transactions0
No derivative transactions reported